According to Regeneron Pharmaceuticals's latest financial reports the company's current earnings are NZ$13.84 Billion. In 2023 the company made an earning of NZ$7.30 Billion a decrease over its 2022 earnings that were of NZ$8.45 Billion. The earnings displayed on this page is the company's Pretax Income.